EMERALD MUTUAL FUND ADVISERS TRUST - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 37 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EMERALD MUTUAL FUND ADVISERS TRUST ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2013$6,093,000
-58.6%
132,862
-68.4%
0.36%
-64.2%
Q3 2013$14,734,000
+387.6%
421,082
+92.8%
1.02%
+98.8%
Q2 2013$3,022,000218,3810.51%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2013
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders